Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port;Incidence, prévalence et facteurs de risque de survenue d'une première complication infectieuse sur chambres à cathéter implantables

Medecine et Maladies Infectieuses

Volumn 39, Issue 4, 2009, Pages 252-258

  Crisinel, M ^a   Mahy, S ^a   Ortega Debalon, P ^a   Buisson, M ^a   Favre, J P ^a   Chavanet, P ^a   Piroth, L ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Catheter infection; Totally implantable venous access ports

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CENTRAL VENOUS CATHETER; CHEMOTHERAPY; DRUG ADMINISTRATION; FOLLOW UP; HUMAN; IMPLANTABLE PORT SYSTEM; INCIDENCE; INFECTION; INFECTION RISK; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEOPLASM; PARENTERAL NUTRITION; PREVALENCE; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 64749114298     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.11.004     Document Type: Article

References (36)

1. Bow E.J., Kilpatrick M.G., and Clinch J.J. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs and impact on quality of life. J Clin Oncol 17 (1999) 1267
2. Sarzo G., Finco C., Parise P., et al. Insertion of prolonged venous access device: a comparison between surgical cutdown and percutaneous techniques. Chir Ital 56 (2004) 437-442
3. Chang H.M., Hsieh C.B., Hsieh H.F., et al. An alternative technique for totally implantable central venous access devices. A retrospective study of 1311 cases. Eur J Surg Oncol 32 (2006) 90-93
4. Inoue Y., Nezu R., Nakai S., Takagi Y., and Okada A. Spontaneous partial fracture of the catheter of a totally implantable subcutaneous infusion port. JPEN J Parenter Enteral Nutr 16 (1992) 75-77
5. Maisey N.R., Sacks N., and Johnston S.R. Catheter fracture: a rare complication of totally implantable venous devices. Breast 12 (2003) 287-289
6. Kurul S., Saip P., and Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 3 (2002) 684-692
7. Hartkamp A., van Boxtel A.J., Zonnenberg B.A., and Witteveen P.O. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57 (2000) 215-223
8. Mandala M., Curigliano G., Bucciarelli P., et al. Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter. Ann Oncol 15 (2004) 590-593
9. Greene F.L., Moore W., Strickland G., and McFarland J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). South Med J 81 (1988) 580-583
10. Carde P., Cosset-Delaigue M.F., Laplanche A., and Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 25 (1989) 939-944
11. Johansson E., Bjorkholm M., Bjorvell H., et al. Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia: a randomized study. Support Care Cancer 12 (2004) 99-105
12. Raad I., Hanna H., and Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention and management. Lancet Infect Dis 7 (2007) 645-657
13. Bouza E., Burillo A., and Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8 (2002) 265-274
14. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
15. Vescia S., Baumgartner A.K., Jacobs V.R., et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19 (2008) 9-15
16. Schwarz R.E., Groeger J.S., and Coit D.G. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79 (1997) 1635-1640
17. Biffi R., Corrado F., de Braud F., et al. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Eur J Cancer 33 (1997) 1190-1194
18. Wolosker N., Yazbek G., Nishinari K., et al. Totally implantable venous catheters for chemotherapy: experience in 500 patients. Sao Paulo Med J 122 (2004) 147-151
19. Biffi R., Pozzi S., Agazzi A., et al. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol 15 (2004) 296-300
20. Freytes C.O., Reid P., and Smith K.L. Long-term experience with a totally implanted catheter system in cancer patients. J Surg Oncol 45 (1990) 99-102
21. Torramade J., Hernandez J.L., Cienfuegos J.A., et al. Implantable devices for central venous access in cancer patients. Our experience in 217 cases. Med Clin (Barc) 98 (1992) 731-733
22. Harvey W.H., Pick T.E., Reed K., and Solenberger R.I. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet 169 (1989) 495-500
23. Lokich J.J., Bothe Jr. A., Benotti P., and Moore C. Complications and management of implanted venous access catheters. J Clin Oncol 3 (1985) 710-717
24. Bothe Jr. A., Piccione W., Ambrosino J.J., Benotti P.N., and Lokich J.J. Implantable central venous access system. Am J Surg 147 (1984) 565-569
25. Cortelezzia A., Fracchiolla N.S., Maisonneuve P., et al. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma 44 (2003) 1495-1501
26. Nicastri E., Petrosillo N., Viale P., and Ippolito G. Catheter-related bloodstream infections in HIV-infected patients. Ann N Y Acad Sci 946 (2001) 274-290
27. Marra A.R., Opilla M., Edmond M.B., and Kirby D.F. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 41 (2007) 19-28
28. Astagneau P., Maugat S., Tran-Minh T., et al. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol 20 (1999) 494-498
29. Morales M., Mendez-Alvarez S., Martin-Lopez J.V., Marrero C., and Freytes C.O. Biofilm: the microbial "bunker" for intravascular catheter-related infection. Support Care Cancer 12 (2004) 701-707
30. Costerton J.W., Montanaro L., and Arciola C.R. Biofilm in implant infections: its production and regulation. Int J Artif Organs 28 (2005) 1062-1068
31. Sandoe J.A., Wysome J., West A.P., Heritage J., and Wilcox M.H. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother 57 (2006) 767-770
32. Giacometti A., Cirioni O., Ghiselli R., et al. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49 (2005) 4042-4045
33. Boersma R.S., Jie K.S., Verbon A., van Pampus E.C., and Schouten H.C. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 19 (2008) 433-442
34. Timsit J.F., Farkas J.C., Boyer J.M., et al. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors and relationship with catheter-related sepsis. Chest 114 (1998) 207-213
35. Fernandez-Hidalgo N., Almirante B., Calleja R., et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 57 (2006) 1172-1180
36. Fortun J., Grill F., Martin-Davila P., et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58 (2006) 816-821